Cancela MB, Winter U, Zugbi S, Dinardi M, et al. Mimicking Retinoblastoma Treatment With Repeated Topotecan or Melphalan Develops Cross-Resistance to Classic Agents But Not to Repurposed Drugs. Invest Ophthalmol Vis Sci 2024;65:14.
PMID: 39636723